ArticleWorld journal of urology2025
Silencing of Rac1 and Arf6 reduces time-dependent and carbachol-induced contractions, proliferation, survival and growth in human bladder smooth muscle cells.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeStorage symptoms in overactive bladder are explained by detrusor contractions and bladder wall thickening. Arf6 and Rac1 are monomeric GTPases with newly emerging roles in smooth muscle contraction and proliferation. Here, we investigated human bladder smooth muscle cells (hBSMC) functions after silencing of Arf6 or Rac1.
methodshBSMC were transfected with Arf6- or Rac1-specific or scrambled siRNA (controls), and characterized using collagen contraction assays, for proliferation (EdU, Ki67), viability, growth in colony formation assays and actin organization.
resultsArf6 and Rac1 silencing was confirmed by RT-PCR. Time-dependent contractions (0.5-6 h after assay initiation) were reduced in Arf6- and Rac1-silenced cells (36% Arf6, 28% Rac1, after 6 h), compared to scramble-transfected cells. Carbachol (3 µM) increased the time-dependent contractions, which were reduced by silencing of Arf6 (40-62%, 0.5-6 h) or Rac1 (30-59% at 0.5-6 h). With U46619 or endothelin-1, time-dependent contractions were similar to contractions without agonists, but again reduced in Arf6- and Rac1-silenced cells. Compared to scramble-transfected cells, silencing reduced the proliferation rate (Arf6 52%, Rac1 33%), Ki67 mRNA expression (89%, 91%), colony formation (63%, 66%), viability (Arf6 up to 84%, Rac1 up to 85%), and actin polymerization (30%, 31%).
conclusionsArf6 and Rac1 promote time-dependent and carbachol-induced contractions of hBSMC, which may be mediated by actin polymerization. Simultaneously, Arf6 and Rac1 promote proliferation, growth and survival in hBSMC. Arf6 and Rac1 may be potentially involved in detrusor overactivity, bladder wall thickening and medical treatment of overactive bladder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.